BPGbio, Inc., a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and ...

But glioblastoma, also known as glioblastoma multiforme, should not be ignored. It is a rare tumour with cases of less than 10 per 100,000 people across the globe, as per a 2017 research published by ...

In 2016, cancer biologist Johanna Joyce of the Memorial Sloan Kettering Cancer Center published a study in Science that ...

Researchers at the Joint Department of Biomedical Engineering at UNC and North Carolina State University recently received a $3.15 million grant from the National Cancer Institute.

Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved its new Head Flexible Electrode (HFE) transducer arrays for use with Optune Gio® for the treatment of ...

Expert Rev Anticancer Ther. 2012;12(5):643-654. In a Phase II study of enzastaurin in heavily pretreated patients with recurrent GBM, an objective radiographic response rate of 26% was shown at ...

Baljit Ahluwalia, from Pinner, remembers her mother, Harbans Kaur Walia, as “an absolute powerhouse of a woman, who held our ...

Novocure (NVCR) announced that the FDA approved its new head flexible electrode, or HFE, transducer arrays for use with Optune Gio for the ...

Glioblastoma Multiforme Treatment Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033 You Can Now Pre Order Your Report To Get A Swift Deliver With All Your Needs ” - The ...

HOUSTON, TX / ACCESSWIRE / November 18, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a ...

Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha ...